New York Blood Center

New York Blood Center is one of the largest independent, community-based nonprofit blood centers in the United States, established in 1964. It operates laboratories that conduct patient antibody testing, blood typing, and antigen analysis, as well as HLA testing for bone marrow and cord blood donors, platelet recipients, and investigations related to transfusion-related acute lung injury (TRALI). Each year, New York Blood Center supplies approximately one million blood products to hospitals across the Northeast, playing a crucial role in saving the lives of patients undergoing cancer treatments, surgeries, or those suffering from conditions such as AIDS, sickle cell anemia, and hemophilia. Its mission is to ensure a safe and reliable blood supply through collaboration with community and corporate partners, along with the support of blood donors and volunteers.

Karina Yazdanbakhsh

Executive Director

1 past transactions

KaloCyte

Seed Round in 2022
KaloCyte, Inc. is a pre-clinical stage healthcare biotech company based in Baltimore, Maryland, founded in 2016. The company focuses on developing ErythroMer, a dried and bio-inspired artificial red blood cell intended to address life-threatening blood loss in situations where stored red blood cells are either unavailable or unsuitable for use. ErythroMer aims to provide context-dependent oxygen delivery while minimizing complications such as vasoconstriction and methemoglobin formation. This innovative approach seeks to enhance trauma care services by offering an effective alternative for managing traumatic hemorrhage when traditional blood supplies are inadequate.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.